| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 05/14/2009 | WO2009060209A1 6,6-fused bicyclic aromatic compounds and their therapeuti use |
| 05/14/2009 | US20090124655 Heterocyclic derivatives as modulators of ion channels |
| 05/13/2009 | CN101429161A Synthesis of PET imaging agent prosome isoquinoline methanamide derivant |
| 05/13/2009 | CN101428236A Iminium salts in cleaning compositions. |
| 05/12/2009 | US7531557 oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; alcoholism; 6-(2-Fluoro-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-nicotinamide |
| 05/07/2009 | WO2009057528A1 Kit for use in production of molecular probe for pet drug screening |
| 05/07/2009 | WO2009057086A1 Novel r,r'-atracurium salts |
| 05/07/2009 | US20090118327 Substituted 1-amino-4-phenyl-dihydroisoquinolines, methods for the production thereof, use thereof as a medicament, and medicaments containing them |
| 05/07/2009 | US20090117586 Fungal cell wall synthesis gene |
| 05/07/2009 | CA2702535A1 Novel r,r'-atracurium salts |
| 05/07/2009 | CA2643394A1 Ligands, their preparation and uses thereof in asymmetric reactions |
| 05/06/2009 | EP2054389A1 6-substituted isoquinoline derivatives as rock-1 inhibitors |
| 05/06/2009 | EP2054383A2 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 05/06/2009 | EP1729774A4 Pyrrolidine compounds |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101426480A Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/05/2009 | CA2267247C Heteroaryloxyethylamines as 5-ht1a ligands |
| 04/30/2009 | WO2007109172A3 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 04/30/2009 | WO2007069268A3 A process for the preparation of substantially pure 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives |
| 04/30/2009 | US20090108746 Anthracene-based compound and organic light emitting device employing the same |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524861 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 04/23/2009 | WO2009052350A1 Amine linked modulators of y-secretase |
| 04/23/2009 | WO2009025914A3 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 04/23/2009 | US20090105474 Novel anthranilic acid derivative or salt thereof |
| 04/23/2009 | US20090105278 Selective inhibitors of human corticosteroid syntheses |
| 04/23/2009 | CA2703636A1 Amine linked modulators of .gamma.-secretase |
| 04/22/2009 | EP2050452A1 indenoisoquinolines as topoisomerase inhibitors I useful as antineoplastic agents |
| 04/22/2009 | CN100480248C Malonamide derivatives as gamma-secretase inhibitors |
| 04/22/2009 | CN100480241C Kukoline C ring modified derivative and synthesis method thereof |
| 04/21/2009 | US7521461 2-{[4-(2-Oxo-2-{[4-(trifluoromethyl)benzyl]amino)ethyl)phenoxy]methyl}benzoic acid; peroxisome proliferator activated receptors alpha and gamma agonist; antidiabetic agents; Insulin Resistance Syndrome (IRS); cardiovascular disorders; myocardial infarction; stroke; atherosclerosis; dyslipidemia |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | CA2517451C Preparation of quinapril hydrochloride |
| 04/16/2009 | WO2006058016A3 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 04/16/2009 | US20090099229 Isoquinolines as IGF-1R Inhibitors |
| 04/16/2009 | US20090099221 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors |
| 04/16/2009 | US20090099133 Isoquinolines Derivatives as Igf-1R Inhibitors |
| 04/16/2009 | US20090098636 Fungal cell wall synthesis gene |
| 04/15/2009 | EP2046789A2 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 04/15/2009 | EP2046753A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/15/2009 | EP2046752A1 Vr1 vanilloid receptor antagonists with a iononic substructure |
| 04/15/2009 | CN101407495A Preparations and uses of isoquinolinium compounds and salts thereof |
| 04/15/2009 | CN101407494A Preparations and uses of isoquinolinium compounds and salts thereof |
| 04/15/2009 | CN101407471A Compound capable of binding S1P receptor and pharmaceutical use thereof |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/14/2009 | US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | US7517594 Charge transfer layers; organic electronic devices |
| 04/09/2009 | WO2009044019A2 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/09/2009 | WO2009044018A2 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 04/09/2009 | US20090093517 Bis1,2,3,4-tetrahydroisoquinoline derivatives and their uses as pharmaceuticals |
| 04/09/2009 | US20090093493 1-phenylalcoxy-2-beta-phenylethyl derivatives as p-glycoprotein (p-gp) inhibitors useful in drug resistance events |
| 04/09/2009 | CA2694322A1 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/09/2009 | CA2694313A1 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 04/08/2009 | EP2045243A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 04/08/2009 | EP2044028A2 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif) |
| 04/08/2009 | EP2044027A2 Fused bicyclic compounds interacting with the histamine h4 receptor |
| 04/08/2009 | EP2044017A2 Substituted phenyl acetic acids as dp-2 antagonists |
| 04/08/2009 | CN101405269A Substituted 1-amino-4-phenyl-dihydroisoquinolines, method for the production thereof, use thereof as a medicament, and medicaments containing them |
| 04/08/2009 | CN101402602A Degradation recycling method for by-product in synthesis of tetrahydrochysene isoquinoline derivative |
| 04/08/2009 | CN101402601A Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/08/2009 | CN100475209C Anti-coronavirus drug |
| 04/07/2009 | US7514543 Immunoglobulin fusion for use as therapeutic tool in prevention and treatment of chronic progression of atherosclerosis in diabetic patients |
| 04/07/2009 | US7514475 Benzylamine analogues |
| 04/02/2009 | WO2009040288A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/02/2009 | US20090088450 5-ht7 receptor antagonists |
| 04/02/2009 | CA2700277A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/01/2009 | EP2041094A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 04/01/2009 | EP2041087A1 2 -oxybenzamide derivatives as parp inhibitors |
| 04/01/2009 | EP1611102A4 Using alkylmetal reagents for directed metalation of azaaromatics |
| 04/01/2009 | CN100473654C S type 4-substituted hydroxypyranoindolidine compound and derivatives and preparation thereof |
| 03/31/2009 | US7511072 7-amido-isoindolyl compounds and methods of its use |
| 03/31/2009 | US7511060 Opiate intermediates and methods of synthesis |
| 03/26/2009 | WO2009007457A3 Compounds and methods for modulating rho gtpases |
| 03/26/2009 | US20090082393 New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090079331 Compound and organic light-emitting device |
| 03/25/2009 | EP2039682A1 Salts for adding angiotensin conversion enzyme inhibitors to NO-donor acids, method of preparing same and pharmaceutical compositions containing them |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | CN101391973A Salts for adding angiotensin conversion enzyme inhibitors to no-donor acids, method of preparing same and pharmaceutical compositions containing them |
| 03/24/2009 | US7507828 Such as quinoline-8-carboxylic acid [5-(2-mercapto-acetylamino)-pentyl]-amide; increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases |
| 03/24/2009 | US7507700 Cleaning compounds; washing, rinsing fabrics, surfaces; reacting halohydrin with a substituted or unsubstituted 3,4-dihydroisoquinoline to form an alcohol salt; sulfating to produce iminium containing compound |
| 03/19/2009 | WO2009036144A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 03/19/2009 | WO2009013299A3 Novel bradykinin b1 antagonists |
| 03/19/2009 | US20090075978 Substituted propiolic acid amides and their use for producing drugs |
| 03/19/2009 | US20090075975 Arylsulfonamides and uses related thereto |
| 03/19/2009 | CA2699384A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2035386A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 03/18/2009 | EP2035385A2 Inhibitors of akt (protein kinase b) |
| 03/18/2009 | EP2035380A2 Parp inhibitors |
| 03/18/2009 | EP1689380A4 Method for treating adamts-5-associated disease |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/17/2009 | US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 03/17/2009 | US7504393 Benzylamine analogues |
| 03/17/2009 | US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/12/2009 | WO2009032840A1 Fluorine- substituted 2 ', 6 ' -dimethyl-l-tyrosine-1, 2,3, 4-tetrahydr0is0quin0line-3-carb0xylic acid peptides (dmt-tic) for use as myu- and delta-opioid receptor probes in |